Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 13, 2019Science Translational MedicineOpen Access

ZEB1 suppression sensitizes KRAS mutant cancers to MEK inhibition by an IL17RD-dependent mechanism

View Full Paper
Ask AI
Bookmark
Share

Authors

DPDavid H. PengThe University of Texas MD Anderson Cancer CenterSKSamrat T. KunduThe University of Texas MD Anderson Cancer CenterJFJared J. FradetteThe University of Texas MD Anderson Cancer Center

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Peng et al. (2019) studied this question.

synapsesocial.com/papers/6a72dcd793a4d5cf641ae730https://doi.org/10.1126/scitranslmed.aaq1238
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Restoring E-Cadherin Expression Increases Sensitivity to Epidermal Growth Factor Receptor Inhibitors in Lung Cancer Cell Lines2006 · 534 citations
  2. 2The microRNA-200/Zeb1 axis regulates ECM-dependent β1-integrin/FAK signaling, cancer cell invasion and metastasis through CRKL2016 · 74 citations
  3. 3Loss of hSef promotes metastasis through upregulation of EMT in prostate cancer2017 · 28 citations
  4. 4An autocrine TGF-β/ZEB/miR-200 signaling network regulates establishment and maintenance of epithelial-mesenchymal transition2011 · 583 citations